US/UK/Canada

Share

Contacts

  • Elos Medtech AB (publ)
    Torsgatan 5B, 411 04 Göteborg
    +46 10 - 171 20 00
    http://www.elosmedtech.com

    • Quotes

    “We will continue to collaborate with our present customers, but also increase our collaboration with technical partners”
    Soren Olesen, Dental Business Director, Elos Medtech
    “Keeping a close dialogue with our partners and maintaining a high level of competence has led to a product portfolio with the right focus – simple and innovative dental products for an open digital workflow.”
    Soren Olesen, Dental Business Director, Elos Medtech
    Elos Medtech is excited to highlight orthopaedics as one of the primary areas of focus and to execute on our market specific strategies. This is a natural step toward achieving our growth targets and capitalizing on our 2015 acquisition of Onyx Medical
    Jan Wahlström, CEO and President.
    Pick a time period -
    Tags ( Active)

    Elos Medtech Nomination Committee appointed for the 2023 Annual General Meeting

    In accordance with the decision of the 2022 Annual General Meeting the Nomination Committee shall consist of not less than three and not more than five members. In addition, the Chairman of the Board shall be co-opted to the Nomination Committee. Based on the shareholder statistics on 31 August 2022 kept by Euroclear, the Chairman of the Board will offer the three largest shareholders based on the largest voting rights, as well as the shareholder with the largest proportion of equity to appoint members to the Nomination Committee. If the same shareholder is both among the three largest in

    Elos Medtech Nomination Committee appointed for the 2022 Annual General Meeting

    In accordance with the decision of the 2021 Annual General Meeting the Nomination Committee shall consist of not less than three and not more than five members. In addition, the Chairman of the Board shall be co-opted to the Nomination Committee. Based on the shareholder statistics on 31 August 2021 kept by Euroclear, the Chairman of the Board will offer the three largest shareholders based on the largest voting rights, as well as the shareholder with the largest proportion of equity to appoint members to the Nomination Committee. If the same shareholder is both among the three largest in

    Elos Medtech Nomination Committee appointed ahead of Annual General Meeting 2018

    In accordance with resolutions passed at the Annual General Meeting in 2017, the Elos Medtech Nomination Committee shall comprise no fewer than four and no more than six members, of whom one is to be the Chairman of the Board. The members are to be appointed by those shareholders who, at the end of the month of August, are the largest shareholders in terms of voting rights in the company, as well as by the party who addition to the aforementioned is the largest shareholder. When appointing the Nomination Committee, the rules of the Swedish Code of Corporate Governance (the Code) are to

    The Nomination Committee´s proposal for new Chairman and new Board Member.

    As Stig-Arne Blom has announced that he will not stand for re-election as Board Member and Chairman of Elos Medtech AB the Nomination Committee will propose to the Annual General Meeting to appoint Yvonne Mårtensson as new Chairman. Yvonne Mårtensson has been a Board Member of Elos Medtech since 2015. In addition to Elos Medtech she also holds Board Member positions in Arcoma, Synthetic MR and SwedenBIO. Furthermore, the Nomination Committee will propose Jon Risfelt to be appointed as new Board Member. Jon Risfelt is Chairman or Board Member of several public and private companies,

    Elos Medtech Nomination Committee appointed ahead of Annual General Meeting 2017

    In accordance with resolutions passed at the Annual General Meeting in 2016, the Elos Medtech Nomination Committee shall comprise no fewer than four and no more than six members, of whom one is to be the Chairman of the Board. The members are to be appointed by those shareholders who, at the end of the month of August, are the largest shareholders in terms of voting rights in the company, as well as by the party who addition to the aforementioned is the largest shareholder. When appointing the Nomination Committee, the rules of the Swedish Code of Corporate Governance (the Code) are to

    Anders Birgersson proposed as Board member of Elos Medtech AB

    The Nomination Committee of Elos Medtech AB will propose that the Annual General Meeting re-elect Board members Stig-Arne Blom (Chairman of the Board), Agneta Bengtsson Runmarker, Jeppe Magnusson, Yvonne Mårtensson, Mats Nilsson and Thomas Öster. The Nomination Committee also proposes Anders Birgersson to be elected as a new Board member. Anders Birgersson is CEO of VBG Group AB since 2001. He is a Board Member of Christian Berner Tech Trade AB, Sparbanken Lidköping AB and KMT Precision Grinding AB. Anders Birgersson has a Master of Engineering at Chalmers University of Technology and

    Elos Medtech Nomination Committee appointed ahead of Annual General Meeting 2016

    In accordance with resolutions passed at the Annual General Meeting in 2015, the Elos Medtech Nomination Committee shall comprise no fewer than four and no more than six members, of whom one is to be the Chairman of the Board. The members are to be appointed by those shareholders who, at the end of the month of August, are the largest shareholders in terms of voting rights in the company, as well as by the party who addition to the aforementioned is the largest shareholder. When appointing the Nomination Committee, the rules of the Swedish Code of Corporate Governance (the Code) are to

    Elos Nomination Committee appointed ahead of Annual General Meeting 2015

    In accordance with resolutions passed at the Annual General Meeting in 2014, the Elos Nomination Committee shall comprise no fewer than four and no more than six members, of whom one is to be the Chairman of the Board. The members are to be appointed by those shareholders who, at the end of the month of September, are the largest shareholders in terms of voting rights in the company, as well as by the party who addition to the aforementioned is the largest shareholder. If a shareholder should waive his/her entitlement to appoint a member, such entitlement switches to the next largest

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media

    Twitter